Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
Wyeth Opens Biotech Production Facility in Ireland
Wyeth Pharmaceuticals opened its 1.2 million-sf Grange Castle biotech production facility on September 8, 2005. Located in South County Dublin, Ireland, the $2 billion project began site work in October of 2002. Employing over 1,000 workers, the facility is comprised of three separate buildings: a drug development unit, a drug substance site, and a drug product facility. Production will begin on a phased basis over the next four years.
University of Louisville To Build Regional Biosafety Laboratory
The National Institutes of Health's National Institute for Allergy and Infectious Diseases (NIAID) has awarded the University of Louisville a $22 million federal grant to construct a biodefense research laboratory on its Shelby campus. One of thirteen BSL-3 Regional Biosafety Laboratories in the nation funded by NIAID since 2003, the 45,000-sf facility will be supported by $12.6 million in University funding. The building will house the University's Center for Predictive Medicine.
George Mason University Constructs National Center for Biodefense and Infectious Diseases
The National Institutes of Health's National Institute of Allergy and Infectious Diseases has awarded George Mason University (GMU) a $25-million grant to construct a new BSL-3 biocontainment laboratory in Fairfax, Va. The facility will be part of GMU's $45-million National Center for Biodefense and Infectious Diseases, an 83,000-sf facility that will accommodate research on diseases considered to be potential bioterror threats.
University of Massachusetts Dartmouth Breaks Ground on Botulism Research Center
The University of Massachusetts Dartmouth broke ground in September 2005 on a $9-million, 20,000-sf research center dedicated to the study of botulism, a potential bioterrorism threat.
UMDNJ Completes $72 Million Child Health Institute
The University of Medicine and Dentistry of New Jersey (UMDNJ) has completed construction of the 145,000-sf Child Health Institute in New Brunswick, N.J. Part of the Robert Wood Johnson Medical School of UMDNJ, the $72 million facility was developed in partnership with the New Brunswick Development Corporation. Designed by Princeton-based The Hillier Group, the comprehensive biomedical research center will accommodate research on the prevention, treatment and cure of childhood diseases with an emphasis on translational medicine.